Gradian Diagnostics
About
Gradian Diagnostics is a biotechnology company that focuses on developing Next-Gen medical and diagnostics technologies. Its philosophy is to take a practical approach to develop its portfolio. The company believes that inspiration must always be backed up by a heavy dose of quantitative evidence and apply hard-nosed management fundamentals to ensure science actually turns into commercially successful products that make a the difference in the lives of patients. The company was founded in 2018 and is headquartered in Miami Beach, Florida.
Gradian Diagnostics is one of 16 Biotechnology companies we track in South Florida — 2% of the region's 662 startups.
Similar companies
View allASP IsotopesBiotechnology | Est. 2021 | MIA | $372M |
SyncromuneBiotechnology | Est. 2020 | MIA | $155M |
Pasithea TherapeuticsBiotechnology | Est. 2020 | MIA | $104M |
Myosin TherapeuticsBiotechnology | Est. 2020 | MIA | $15M |
WeoBiotechnology | Est. 2017 | MIA | $10M |
Details
- Region
- South Florida / Miami
- City
- Miami Beach
- Founded
- 2018
- Sector
- Biotechnology
- Founders
- Alejandro Malbran
- Website
- gradian-dx.com
South Florida / Miami
South Florida anchors the state's fintech, crypto, and Latin America-facing economy, with a deep bilingual talent pool across Miami, Fort Lauderdale, and Palm Beach.